Verition Fund Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-184,445
| Closed | -$1.68M | – | 3969 |
|
|
2025
Q2 | $1.68M | Buy |
184,445
+12,422
| +7% | +$91.4K | 0.01% | 2077 |
|
|
2025
Q1 | $1.37M | Buy |
172,023
+3,008
| +2% | +$22K | 0.01% | 1861 |
|
|
2024
Q4 | $918K | Buy |
169,015
+32,593
| +24% | +$199K | ﹤0.01% | 2111 |
|
|
2024
Q3 | $985K | Sell |
136,422
-1,180
| -0.9% | -$10.8K | 0.01% | 1897 |
|
|
2024
Q2 | $1.49M | Sell |
137,602
-2,847
| -2% | -$36.5K | 0.01% | 1440 |
|
|
2024
Q1 | $2.63M | Buy |
140,449
+7,949
| +6% | +$183K | 0.02% | 1059 |
|
|
2023
Q4 | $2.87M | Sell |
132,500
-12,800
| -9% | -$254K | 0.02% | 667 |
|
|
2023
Q3 | $2.99M | Buy |
145,300
+6,195
| +4% | +$179K | 0.03% | 630 |
|
|
2023
Q2 | $6.54M | Buy |
139,105
+2,008
| +1% | +$99.9K | 0.09% | 305 |
|
|
2023
Q1 | $5.75M | Buy |
137,097
+2,431
| +2% | +$105K | 0.08% | 321 |
|
|
2022
Q4 | $5.14M | Sell |
134,666
-2,191
| -2% | -$83.7K | 0.08% | 299 |
|
|
2022
Q3 | $5.36M | Sell |
136,857
-3,345
| -2% | -$129K | 0.06% | 384 |
|
|
2022
Q2 | $4.53M | Buy |
+140,202
| New | +$4.7M | 0.09% | 296 |
|
|
2021
Q3 | – | Sell |
-11,146
| Closed | -$633K | – | 2258 |
|
|
2021
Q2 | $633K | Buy |
+11,146
| New | +$788K | 0.01% | 988 |
|
|
2020
Q1 | – | Sell |
-59,047
| Closed | -$4.26M | – | 993 |
|
|
2019
Q4 | $4.26M | Buy |
+59,047
| New | +$7.26M | 0.08% | 165 |
|
|
2019
Q2 | – | Sell |
-1,830
| Closed | -$291K | – | 1328 |
|
|
2019
Q1 | $291K | Buy |
+1,830
| New | +$265K | 0.01% | 848 |
|
|
2018
Q4 | – | Sell |
-1,963
| Closed | -$277K | – | 1197 |
|
|
2018
Q3 | $277K | Buy |
+1,963
| New | +$303K | 0.01% | 1059 |
|
|
2018
Q2 | – | Sell |
-1,606
| Closed | -$259K | – | 1279 |
|
|
2018
Q1 | $259K | Buy |
+1,606
| New | +$273K | 0.02% | 888 |
|
Other funds holding SAGE
IA
HNB